carvedilol has been researched along with Arteriosclerosis, Coronary in 15 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "A systematic review and meta-analysis was performed to evaluate the effects of carvedilol versus metoprolol on the incidence of postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting in randomized controlled trials." | 8.90 | Meta-analysis comparing carvedilol versus metoprolol for the prevention of postoperative atrial fibrillation following coronary artery bypass grafting. ( Aradi, D; Beavers, CJ; Biondi-Zoccai, G; Brugts, J; Chatterjee, S; D'Ascenzo, F; DiNicolantonio, JJ; Gasparini, M; Komócsi, A; Lavie, CJ; Meier, P; Menezes, AR; O'Keefe, JH; Vorobcsuk, A, 2014) |
| "Our previous study showed that static handgrip caused increases in the plasma adrenomedullin (ADM) both in patients with heart failure (HF) and healthy subjects." | 7.73 | Effect of adrenergic blockade on plasma adrenomedullin concentration during static handgrip in patients with heart failure. ( Cybulski, G; Krzemiński, K; Mikulski, T; Nazar, K, 2006) |
| "Bisoprolol was started at 1." | 6.76 | Comparison of effectiveness of carvedilol versus bisoprolol for prevention of postdischarge atrial fibrillation after coronary artery bypass grafting in patients with heart failure. ( Arisi, G; Caminiti, G; Iellamo, F; Madonna, M; Marazzi, G; Massaro, R; Righi, D; Rosano, GM; Volterrani, M, 2011) |
| "Carvedilol is an antioxidant that inhibits smooth muscle cell proliferation and migration." | 6.76 | Two-year clinical outcome after carvedilol-loaded stent implantation in patients with coronary artery disease. ( Ahn, Y; Cho, JG; Hong, YJ; Jeong, MH; Kang, JC; Kim, HK; Kim, JH; Kim, KH; Kim, SS; Kim, W; Ko, JS; Lee, MG; Park, HW; Park, JC; Park, KH; Sim, DS; Yoon, HJ; Yoon, NS, 2011) |
| "A systematic review and meta-analysis was performed to evaluate the effects of carvedilol versus metoprolol on the incidence of postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting in randomized controlled trials." | 4.90 | Meta-analysis comparing carvedilol versus metoprolol for the prevention of postoperative atrial fibrillation following coronary artery bypass grafting. ( Aradi, D; Beavers, CJ; Biondi-Zoccai, G; Brugts, J; Chatterjee, S; D'Ascenzo, F; DiNicolantonio, JJ; Gasparini, M; Komócsi, A; Lavie, CJ; Meier, P; Menezes, AR; O'Keefe, JH; Vorobcsuk, A, 2014) |
| "Our previous study showed that static handgrip caused increases in the plasma adrenomedullin (ADM) both in patients with heart failure (HF) and healthy subjects." | 3.73 | Effect of adrenergic blockade on plasma adrenomedullin concentration during static handgrip in patients with heart failure. ( Cybulski, G; Krzemiński, K; Mikulski, T; Nazar, K, 2006) |
| "Bisoprolol was started at 1." | 2.76 | Comparison of effectiveness of carvedilol versus bisoprolol for prevention of postdischarge atrial fibrillation after coronary artery bypass grafting in patients with heart failure. ( Arisi, G; Caminiti, G; Iellamo, F; Madonna, M; Marazzi, G; Massaro, R; Righi, D; Rosano, GM; Volterrani, M, 2011) |
| "Carvedilol is an antioxidant that inhibits smooth muscle cell proliferation and migration." | 2.76 | Two-year clinical outcome after carvedilol-loaded stent implantation in patients with coronary artery disease. ( Ahn, Y; Cho, JG; Hong, YJ; Jeong, MH; Kang, JC; Kim, HK; Kim, JH; Kim, KH; Kim, SS; Kim, W; Ko, JS; Lee, MG; Park, HW; Park, JC; Park, KH; Sim, DS; Yoon, HJ; Yoon, NS, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 7 (46.67) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Syed, MP | 1 |
| Doshi, A | 1 |
| Pandey, D | 1 |
| Kate, Y | 1 |
| Harizi, R | 1 |
| Kónyi, A | 1 |
| DiNicolantonio, JJ | 1 |
| Beavers, CJ | 1 |
| Menezes, AR | 1 |
| Lavie, CJ | 1 |
| O'Keefe, JH | 1 |
| Meier, P | 1 |
| Vorobcsuk, A | 1 |
| Aradi, D | 1 |
| Komócsi, A | 1 |
| Chatterjee, S | 1 |
| D'Ascenzo, F | 1 |
| Gasparini, M | 1 |
| Brugts, J | 1 |
| Biondi-Zoccai, G | 1 |
| Ignjatovic, V | 1 |
| Pavlovic, S | 1 |
| Miloradovic, V | 1 |
| Andjelkovic, N | 1 |
| Davidovic, G | 1 |
| Djurdjevic, P | 1 |
| Stolic, R | 1 |
| Iric-Cupic, V | 1 |
| Simic, I | 1 |
| Ignjatovic, VD | 1 |
| Petrovic, N | 1 |
| Smiljanic, Z | 1 |
| Zdravkovic, V | 1 |
| Simovic, S | 1 |
| Jovanovic, D | 1 |
| Nesic, J | 1 |
| Allen LaPointe, NM | 1 |
| Zhou, Y | 1 |
| Stafford, JA | 1 |
| Hernandez, AF | 1 |
| Kramer, JM | 1 |
| Anstrom, KJ | 1 |
| Vitulano, N | 1 |
| Giubilato, G | 1 |
| Santangeli, P | 1 |
| Ierardi, C | 1 |
| Pieroni, M | 1 |
| Bellocci, F | 1 |
| Crea, F | 1 |
| Marazzi, G | 1 |
| Iellamo, F | 1 |
| Volterrani, M | 1 |
| Caminiti, G | 1 |
| Madonna, M | 1 |
| Arisi, G | 1 |
| Massaro, R | 1 |
| Righi, D | 1 |
| Rosano, GM | 1 |
| Kim, HK | 1 |
| Hong, YJ | 1 |
| Jeong, MH | 1 |
| Kim, W | 1 |
| Kim, SS | 1 |
| Ko, JS | 1 |
| Lee, MG | 1 |
| Sim, DS | 1 |
| Park, KH | 1 |
| Yoon, NS | 1 |
| Yoon, HJ | 1 |
| Kim, KH | 1 |
| Park, HW | 1 |
| Kim, JH | 1 |
| Ahn, Y | 1 |
| Cho, JG | 1 |
| Park, JC | 1 |
| Kang, JC | 1 |
| Merritt, JC | 1 |
| Niebauer, M | 1 |
| Tarakji, K | 1 |
| Hammer, D | 1 |
| Mills, RM | 1 |
| Massing, JL | 1 |
| Baille, N | 1 |
| Raddad, M | 1 |
| Gangloff, C | 1 |
| Lecourtois, P | 1 |
| Koepfli, P | 1 |
| Wyss, CA | 1 |
| Namdar, M | 1 |
| Klainguti, M | 1 |
| von Schulthess, GK | 1 |
| Lüscher, TF | 1 |
| Kaufmann, PA | 1 |
| Krzemiński, K | 1 |
| Nazar, K | 1 |
| Cybulski, G | 1 |
| Mikulski, T | 1 |
| Fox, K | 1 |
| Borer, JS | 1 |
| Camm, AJ | 1 |
| Danchin, N | 1 |
| Ferrari, R | 1 |
| Lopez Sendon, JL | 1 |
| Steg, PG | 1 |
| Tardif, JC | 1 |
| Tavazzi, L | 1 |
| Tendera, M | 1 |
| Thury, A | 1 |
| Van Langenhove, G | 1 |
| Wardeh, AJ | 1 |
| Foley, DP | 1 |
| Serruys, PW | 1 |
| Willich, SN | 1 |
| Jimenez, AH | 1 |
| Tofler, GH | 1 |
| DeSilva, RA | 1 |
| Muller, JE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effects of Selective and Nonselective Beta-blockade on Platelet Aggregation in Patients With Acute Coronary Syndrome[NCT02809820] | Phase 4 | 100 participants (Actual) | Interventional | 2016-05-31 | Completed | ||
| A Single Centre, Retrospective Cohort Study on Post Analysis on the Link Between the Clinical Heart Rate and Outcomes During PCI[NCT02351674] | 15,000 participants (Anticipated) | Observational | 2015-01-31 | Not yet recruiting | |||
| Heart Rate Lowering Efficacy and Respiratory Safety of Ivabradine in Patients With Obstructive Airway Disease[NCT01365286] | Phase 4 | 40 participants (Actual) | Interventional | 2009-05-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for carvedilol and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
[Carvedilol in the everyday interventional cardiology practice].
Topics: Angioplasty, Balloon, Coronary; Carbazoles; Cardiology; Carvedilol; Combined Modality Therapy; Coron | 2017 |
Meta-analysis comparing carvedilol versus metoprolol for the prevention of postoperative atrial fibrillation following coronary artery bypass grafting.
Topics: Adrenergic alpha-1 Receptor Antagonists; Anti-Arrhythmia Agents; Atrial Fibrillation; Carbazoles; Ca | 2014 |
Resting heart rate in cardiovascular disease.
Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Calcium Channel Blockers; Carbazoles; Ca | 2007 |
Resting heart rate in cardiovascular disease.
Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Calcium Channel Blockers; Carbazoles; Ca | 2007 |
Resting heart rate in cardiovascular disease.
Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Calcium Channel Blockers; Carbazoles; Ca | 2007 |
Resting heart rate in cardiovascular disease.
Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Calcium Channel Blockers; Carbazoles; Ca | 2007 |
Further insights into coronary debulking: the EUROCARE trial of directional atherectomy and the PACT trial of pullback atherectomy.
Topics: Adrenergic beta-Antagonists; Antioxidants; Atherectomy, Coronary; Carbazoles; Carvedilol; Coronary A | 2000 |
Pathophysiology and triggers of acute myocardial infarction: clinical implications.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Arousal; Carbazoles; Carvedilol; Circadian Rhy | 1992 |
4 trials available for carvedilol and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Comparison of effectiveness of carvedilol versus bisoprolol for prevention of postdischarge atrial fibrillation after coronary artery bypass grafting in patients with heart failure.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Atrial Fibrillation; Bisoprolol; Carbazoles | 2011 |
Two-year clinical outcome after carvedilol-loaded stent implantation in patients with coronary artery disease.
Topics: Aged; Angioplasty, Balloon, Coronary; Carbazoles; Carvedilol; Coronary Artery Disease; Female; Follo | 2011 |
Beta-adrenergic blockade and myocardial perfusion in coronary artery disease: differential effects in stenotic versus remote myocardial segments.
Topics: Adrenergic beta-Antagonists; Ammonia; Carbazoles; Carbon Isotopes; Carvedilol; Coronary Artery Disea | 2004 |
Further insights into coronary debulking: the EUROCARE trial of directional atherectomy and the PACT trial of pullback atherectomy.
Topics: Adrenergic beta-Antagonists; Antioxidants; Atherectomy, Coronary; Carbazoles; Carvedilol; Coronary A | 2000 |
7 other studies available for carvedilol and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
A rare case of biventricular non-compaction.
Topics: Cardiomyopathies; Carvedilol; Coronary Artery Disease; Dyspnea; Furosemide; Heart Failure; Heart Ven | 2020 |
Influence of Different β-Blockers on Platelet Aggregation in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aspirin; Bisoprolol; Carbazoles; Carvedilol; Clopidog | 2016 |
Association between mortality and persistent use of beta blockers and angiotensin-converting enzyme inhibitors in patients with left ventricular systolic dysfunction and coronary artery disease.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Bisoprolol; Carb | 2009 |
Continuous positive airway pressure treatment in addition to optimal medical therapy for ventricular ectopy in a patient with heart failure and sleep-related breathing disorder.
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme | 2013 |
Comparison of effectiveness of carvedilol versus metoprolol or atenolol for atrial fibrillation appearing after coronary artery bypass grafting or cardiac valve operation.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atenolol; Atrial Fibrillation; Carbazoles; Carvedilol; Coronary | 2003 |
[Benefits of a beta-blocking agent (carvedilol) on bilateral atherosclerotic renal artery stenosis. A case report].
Topics: Adrenergic beta-Antagonists; Aged; Carbazoles; Carvedilol; Coronary Artery Disease; Humans; Hyperten | 2004 |
Effect of adrenergic blockade on plasma adrenomedullin concentration during static handgrip in patients with heart failure.
Topics: Adrenergic beta-Antagonists; Adrenomedullin; Aged; Analysis of Variance; Biomarkers; Blood Pressure; | 2006 |